Science

Diego A. Díaz García: AI-powered NGS profiling reveals high TMB and MLH1/PMS2 loss in MSI+ lung tumors

Diego Díaz García/X

May 13, 2025, 09:18

Diego A. Díaz García: AI-powered NGS profiling reveals high TMB and MLH1/PMS2 loss in MSI+ lung tumors

Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X about recent paper Quentin Dominique Thomas and colleagues authored:

“MSI/dMMR in NSCLC is rare (<1%) but has key implications for immunotherapy.

AI-powered NGS profiling reveals high TMB and MLH1/PMS2 loss in MSI+ lung tumors.

Precision diagnostics for better treatment decisions.”

AI-powered NGS profiling

Title: Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer

Authors: Quentin Dominique Thomas, Julie Adèle Vendrell, Lakhdar Khellaf, Sarah Cavaillon, Xavier Quantin, Jérôme Solassol, Simon Cabello-Aguilar

Read Full Article on ACS Journals.

AI-powered NGS profiling

Read about NSCLC on OncoDaily.

cancer Diego A. Díaz García Jérôme Solassol Julie Adèle Vendrell Lakhdar Khellaf OncoDaily Oncology Quentin Dominique Thomas Sarah Cavaillon Simon Cabello-Aguilar Xavier Quantin

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

20 Posts Not to Miss from ASCO 2025

Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?

Clifford Hudis and Thomas Kurian Discussed AI in Oncology and ASCO Guidelines Assistant at ASCO 2025

Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL